Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence : a prospective, randomized, multicenter phase II trial
- Author
- Piet Ost (UGent) , Dries Reynders (UGent) , Karel Decaestecker (UGent) , Valerie Fonteyne (UGent) , Nicolaas Lumen (UGent) , Aurélie De Bruycker (UGent) , Bieke Lambert (UGent) , Louke Delrue (UGent) , Renée Bultijnck (UGent) , Tom Claeys, Els Goetghebeur (UGent) , Geert Villeirs (UGent) , Kathia De Man (UGent) , Filip Ameye (UGent) , Ignace Billiet, Steven Joniau, Friedl Vanhaverbeke and Gert De Meerleer
- Organization
- Keywords
- POSITRON-EMISSION-TOMOGRAPHY, QUALITY-OF-LIFE, CURATIVE TREATMENT, CLINICAL-TRIALS, DISEASE, RECOMMENDATIONS, RADIOTHERAPY, GUIDELINES, SURVIVAL, QLQ-C30
Downloads
-
(...).pdf
- full text
- |
- UGent only
- |
- |
- 882.23 KB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-8545939
- MLA
- Ost, Piet, et al. “Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence : A Prospective, Randomized, Multicenter Phase II Trial.” JOURNAL OF CLINICAL ONCOLOGY, vol. 36, no. 5, 2018, pp. 446–53, doi:10.1200/JCO.2017.75.4853.
- APA
- Ost, P., Reynders, D., Decaestecker, K., Fonteyne, V., Lumen, N., De Bruycker, A., … De Meerleer, G. (2018). Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence : a prospective, randomized, multicenter phase II trial. JOURNAL OF CLINICAL ONCOLOGY, 36(5), 446–453. https://doi.org/10.1200/JCO.2017.75.4853
- Chicago author-date
- Ost, Piet, Dries Reynders, Karel Decaestecker, Valerie Fonteyne, Nicolaas Lumen, Aurélie De Bruycker, Bieke Lambert, et al. 2018. “Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence : A Prospective, Randomized, Multicenter Phase II Trial.” JOURNAL OF CLINICAL ONCOLOGY 36 (5): 446–53. https://doi.org/10.1200/JCO.2017.75.4853.
- Chicago author-date (all authors)
- Ost, Piet, Dries Reynders, Karel Decaestecker, Valerie Fonteyne, Nicolaas Lumen, Aurélie De Bruycker, Bieke Lambert, Louke Delrue, Renée Bultijnck, Tom Claeys, Els Goetghebeur, Geert Villeirs, Kathia De Man, Filip Ameye, Ignace Billiet, Steven Joniau, Friedl Vanhaverbeke, and Gert De Meerleer. 2018. “Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence : A Prospective, Randomized, Multicenter Phase II Trial.” JOURNAL OF CLINICAL ONCOLOGY 36 (5): 446–453. doi:10.1200/JCO.2017.75.4853.
- Vancouver
- 1.Ost P, Reynders D, Decaestecker K, Fonteyne V, Lumen N, De Bruycker A, et al. Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence : a prospective, randomized, multicenter phase II trial. JOURNAL OF CLINICAL ONCOLOGY. 2018;36(5):446–53.
- IEEE
- [1]P. Ost et al., “Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence : a prospective, randomized, multicenter phase II trial,” JOURNAL OF CLINICAL ONCOLOGY, vol. 36, no. 5, pp. 446–453, 2018.
@article{8545939,
author = {{Ost, Piet and Reynders, Dries and Decaestecker, Karel and Fonteyne, Valerie and Lumen, Nicolaas and De Bruycker, Aurélie and Lambert, Bieke and Delrue, Louke and Bultijnck, Renée and Claeys, Tom and Goetghebeur, Els and Villeirs, Geert and De Man, Kathia and Ameye, Filip and Billiet, Ignace and Joniau, Steven and Vanhaverbeke, Friedl and De Meerleer, Gert}},
issn = {{0732-183X}},
journal = {{JOURNAL OF CLINICAL ONCOLOGY}},
keywords = {{POSITRON-EMISSION-TOMOGRAPHY,QUALITY-OF-LIFE,CURATIVE TREATMENT,CLINICAL-TRIALS,DISEASE,RECOMMENDATIONS,RADIOTHERAPY,GUIDELINES,SURVIVAL,QLQ-C30}},
language = {{eng}},
number = {{5}},
pages = {{446--453}},
title = {{Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence : a prospective, randomized, multicenter phase II trial}},
url = {{http://dx.doi.org/10.1200/JCO.2017.75.4853}},
volume = {{36}},
year = {{2018}},
}
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: